FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression
PR Newswire - WILMINGTON, Del., Oct. 20 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has approved SEROQUEL(R) (quetiapine fumarate) for the treatment of patients with depressive episodes
Source: sev.prnewswire.com
Biovail hikes dividend, shifts strategy
Reuters - BVF.N: Quote , Profile , Research ) said on Wednesday it plans to triple its dividend, pay off debt and focus on drug development as it readies for copycat drugs that will challenge its main anti-depression treatment. The company said it will axe
Source: today.reuters.com
Click here for more information about severe depression severe depression
<< Home